ADXN Addex Therapeutics Ltd
$2.98
Addex Therapeutics Ltd (ADXN) Earnings News
Earnings press releases, previews and reviews for Addex Therapeutics Ltd (ADXN), newest first. Our most recent is review: Addex Narrows Its Loss and Regains GABA-B Rights, but Loses Indivior's USD 330M Milestone Path and Still Lacks Funding for Clinical Work.
Monday
September 28, 2026
1:29 PM ET
Addex Narrows Its Loss and Regains GABA-B Rights, but Loses Indivior's USD 330M Milestone Path and Still Lacks Funding for Clinical Work
Earnings Whispers · Review
Monday
September 28, 2026
1:00 AM ET
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
Thursday
September 24, 2026
1:00 AM ET
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
Thursday
June 25, 2026
1:00 AM ET
Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Monday
June 22, 2026
1:00 AM ET
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
Thursday
April 30, 2026
1:00 AM ET
Addex Reports Full Year 2025 Financial Results and Provides Corporate Update